StockData
Recursion Pharmaceuticals, Inc. logo

Recursion Pharmaceuticals, Inc. (RXRX) stock

RXRXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 8/309% below fair value
$2.83+0.10 (+3.86%)

Close on Nov 18, 2026Market cap $1.51BP/E –Yield –

Recursion Pharmaceuticals revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Recursion Pharmaceuticals's revenue for the twelve months ending Jun 30, 2026 was $54.86M, down 15.1% year over year. For fiscal 2025 it was $74.68M, up 26.9% from the year before. The highest annual figure on record is $74.68M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$74.68M+26.9%
FY2024Dec 31, 2024$58.84M+32.0%
FY2023Dec 31, 2023$44.58M+11.9%
FY2022Dec 31, 2022$39.84M+291.5%
FY2021Dec 31, 2021$10.18M+156.9%
FY2020Dec 31, 2020$3.96M+70.8%
FY2019Dec 31, 2019$2.32M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$7.67M-60.1%
Q1 FY2026Mar 31, 2026$6.47M-56.1%
Q4 FY2025Dec 31, 2025$35.54M+681.7%
Q3 FY2025Sep 30, 2025$5.18M-80.2%
Q2 FY2025Jun 30, 2025$19.22M+33.3%
Q1 FY2025Mar 31, 2025$14.75M+6.9%
Q4 FY2024Dec 31, 2024$4.55M-58.3%
Q3 FY2024Sep 30, 2024$26.08M+147.6%
Q2 FY2024Jun 30, 2024$14.42M+30.9%
Q1 FY2024Mar 31, 2024$13.79M+13.7%
Q4 FY2023Dec 31, 2023$10.89M-20.4%
Q3 FY2023Sep 30, 2023$10.53M-20.0%
Q2 FY2023Jun 30, 2023$11.02M+43.6%
Q1 FY2023Mar 31, 2023$12.13M+127.5%
Q4 FY2022Dec 31, 2022$13.68M+439.9%
Q3 FY2022Sep 30, 2022$13.16M+419.3%
Q2 FY2022Jun 30, 2022$7.67M+201.1%
Q1 FY2022Mar 31, 2022$5.33M+108.2%
Q4 FY2021Dec 31, 2021$2.53M-5.9%
Q3 FY2021Sep 30, 2021$2.53M+147.2%
Q2 FY2021Jun 30, 2021$2.55M+1270.4%
Q1 FY2021Mar 31, 2021$2.56M+4170.0%
Q4 FY2020Dec 31, 2020$2.69M–
Q3 FY2020Sep 30, 2020$1.03M–
Q2 FY2020Jun 30, 2020$186.00K–
Q1 FY2020Mar 31, 2020$60.00K–

More Recursion Pharmaceuticals figures

See a number that looks wrong?